# Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)

> **NCT02953548** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 9 (actual)

## Conditions studied

- Infantile Spasms

## Interventions

- **DRUG:** GWP42003-P

## Key facts

- **NCT ID:** NCT02953548
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-24
- **Primary completion:** 2018-05-07
- **Final completion:** 2018-05-07
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953548, "Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02953548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*